Livestock Vaccines Market - By Animal Type, By Vaccine Type, By Route of administration, By Application, By Distribution Channel - Global Forecast, 2025 - 2034

Livestock Vaccines Market Size

The global livestock vaccines market was valued at 6.4 billion in 2024. The market is expected to grow from USD 6.8 billion in 2025 to USD 12.6 billion in 2034, at a CAGR of 7.1%. The growth of the market is attributed to the growing awareness among farmers about the benefits of vaccination, expansion of industrial livestock farming and technological advancements leading to the development of more effective vaccines.
 

For instance, in December 2024, Agri Advanced Technologies developed Vaccybot, a fully automatic vaccination robot for poultry farming, which will improve animal health and vaccination quality. This robotic technology has a speed capacity of 2,800 birds per hour. Therefore, this automated process of poultry vaccination aimed to expedite the vaccination with reducing personnel cost and simplified the workflow. This tends to expand the vaccination volume thereby stimulating the market growth.
 

Furthermore, the rising prevenances of livestock diseases is one of the significant factors for the growth of the market. According to the study conducted by Oxford Analytica, 20% of poultry globally is affected by some form of the disease each year, affecting the overall global food production. In addition, poultry production has also faced major setback due to the bird flu concern that has impeded industry growth. This has resulted in increasing concerns related to the prevention of diseases spurring the demand for effective poultry vaccines.
 

Livestock animals are the domesticated animals that are kept for agricultural use, including the production of meat, milk, wool and for labor. Major livestock species are poultry, cattle, swine, aquaculture, and sheep and goats. Vaccination is essential in protecting livestock from infectious diseases, improving animal health and productivity, food safety, and lowering economic losses for farmers and the agriculture sector.
 

Livestock Vaccines Market Trends

Growing animal healthcare expenditure, alongside spurred vaccine demands due to other factors like increased focus on sustainable livestock raising, is propelling industry growth.
 

• The sustainable approach ensuring the welfare of the animals and improving productivity while meeting the global food safety requirements is the recent focus of livestock farming.
   
• This shift towards sustainability has created a need for effective disease preventative vaccination programs framed within loss mitigation.
   
• In addition, the awareness of farmers and the governments regarding the economic impact of animal diseases has increased, resulting in bolstered spending towards veterinary healthcare.
   
• For instance, according to the National Animal Disease Program, around 44.57 crore FMD vaccines and 1.6 crore Brucella vaccines have been administered during 2024 in India alone, showing increasing focus of government on livestock sustainability.
   
• Similarly, according to Statista, USD 3.22 billion dollars were spent on livestock vaccines in 2022 and is expected to rise to USD 6.23 billion dollar in 2026. This increasing spending and rising vaccine demand is another significant factor.
   
• Furthermore, growing technology advancement in vaccine development, particularly new delivery methods and multivalent vaccines has also created rapid growth in the livestock animal vaccines sector, stimulating change and increasing vaccine uptake in farming across the world.
   
• In addition, there is an increase in research and development for recombinant DNA and subunit vaccines and shift towards next-gen vaccines.
   

Trump Administration Tariffs

• The recent tariffs imposed by Trump administration on China will impact the Chinese imports of the livestock animal vaccines and medications by raising the costs of raw materials such as APIs and excipients, and veterinary supplies.
   
• Large animal practices is expected to face a 10%-25% price hikes on essential products such as vaccines and antibiotics as stated by Georgia Veterinary Medical Association.
   
• Further, increased costs will strain the farmers economic budget causing delay or lower preventive care, risking herd health.
   
• In longer terms, critical livestock medicine and equipment supply will also get disrupted during important seasonal periods.
   
• In the near future, manufacturers might deal with new challenges such as rising prices, products being less accessible within expected timelines, and stringent cost control measures.
   

Livestock Vaccines Market Analysis

Based on animal type, the global market is segmented into poultry, cattle, swine, aquaculture and sheep and goats. The poultry segment generated the largest market revenue of USD 2.4 billion in 2024 and is projected to reach USD 4.5 billion by 2034, witnessing its prominence throughout the forecast period at a CAGR of 6.5%.
 

• Poultry is the most widely consumed meat in the world due to its affordability and shorter production cycles. According to the OECD-FAO Agricultural Outlook, in 2023, poultry meat is projected to account for nearly half of all meat protein sources through 2032.
   
• Intense farming practices are driven by the growing demand for poultry in developing countries such as Asia and Latin America, thereby increasing the need for preventive vaccination.
   
• Poultry is highly susceptible to the viral and bacterial outbreaks such as Avian influenza, Newcastle disease and Infectious Bursal Disease. According to World Organization for Anima Health, between 2005 and 2020, 246 million poultry died or were culled due to Avian Influenza.
   
• In addition, this concern raises the demand for advanced and effective treatment which has grown the efforts of large veterinary medicine manufacturers to invest in development to meet the industry requirements.
   
• For instance, in February 2025, Boehringer Ingelheim introduced a new range of trivalent vaccine VAXXITEK HVT+IBD+H5 for the poultry. This vaccine offered the protection against the three severe poultry diseases such as Marek’s disease, Infectious Bursal’s Disease, and H5 avian influenza. This launch represented a critical advancement for poultry supporting sustainable farming.

Based on vaccine type, the livestock vaccines market is categorized attenuated live vaccine, conjugate vaccine, inactivated vaccine, recombinant vaccine and other vaccine types. The attenuated live vaccine segment accounted for the highest market share of 45.9% in 2024 and is anticipated to reach to dominate throughout the forecast period at a CAGR of 6.7%.
 

• The use of attenuated live vaccines has is driven owing to their unparalleled capacity to stimulate robust and long term immune responses.
   
• These vaccines employ weakened forms of pathogens since these practically simulate natural infections, requiring fewer doses than inactivated vaccines.
   
• Their higher efficacy in preventing serious diseases in livestock such as foot-and-mouth disease (FMD), brucellosis, and bovine respiratory diseases, has made them the preferred choice for large-scale agriculture industry.
   
• Additionally, live attenuated vaccines often offer faster onset of immunity, which is important in managing the health of the herd in intensive farming operations.
   
• Continuous advancements in their development, strengthening their reliability, have further solidified its position in the market. For instance, in February 2024, BioVet developed Biolumpivaxin, an indegenious live-atteneuated marker vaccine in collaboration with Indian Council of Agricultural Research. This vaccine was developed to treat lumpy skin disease (LSD) in dairy cattle and buffalos. The rollout of the goals vaccine brought about effective changes in the animal healthcare industry by mitigating the risk of cattle mortality while maximizing milk yield.
   

Based on the route of administration, the livestock vaccines market is categorized into oral, parenteral and other routes of administration. The oral segment is expected to hold a prominent position in the market with a growth rate of 6.8% and is poised to reach USD 7.1 billion by 2034.
 

• Oral route provides a convenient, effective, and less stressful way of immunization, particularly with large herds.
   
• Furthermore, oral vaccines can be given more easily via feed or water, minimizing the need for handling which reduces injury risks to both animals and handlers. This method is very effective in mass vaccination programs, especially in poultry, swine, and cattle farming.
   
• It also increases better compliance and coverage and enhances the proportion of the herd or flock protected.
   
• Advances in vaccine formulations have made the stability and effectiveness of oral vaccines stronger which increases their attractiveness. Therefore, convenience, cost effectiveness, and scalability have secured the oral route as prominent segment in the market.
   

Based on the application, the livestock vaccines market is categorized into bacterial infections, viral infections, parasitic infections and other applications. The viral infections segment is expected to hold a prominent position in the market with a growth rate of 7.2% and is poised to reach USD 6.8 billion by 2034.
 

• The rising prevalence and recurrence of viral diseases like FMD, avian influenza, Newcastle diseases, and others continued to affect livestock globally.
   
• According to World Organization of Animal Health (WOAH), FMD is endemic in over 77 countries, affecting 77% of global livestock population among Africa, Middle East, Asia and some parts of Latin America. This disease is susceptible to infection or become carriers of the virus making it a serious concern with vaccination being the primary prevention. For instance, Mongolia experienced an outbreak of FMD disease in 2019 which had been FMD free since 2017 and had put a vaccination program in place.
   
• In addition, as theses viral outbreaks have a high economic impact on the country’s economy, causing loss of billions of dollars through decreased yield This has necessitated to undertake the preventive measures for the vaccination at immediate. According to USDA, Avian Influenza outbreak in 2022 reduced egg inventory by 29 percent in the month of December 2022.
   
• Furthermore, several companies are investing heavily in advancements for viral vaccine technology, driving the market growth. For instance, Zoetis’ Poulvac Procerta HVT-ND is a recombinant vaccine protecting poultry against Newcastle Disease Virus using an HVT vector—providing early immunity and less interference with maternal antibodies.
   

Based on the distribution channel, the global livestock vaccines market is segmented into veterinary hospital pharmacies, retail pharmacies and e-commerce. The veterinary hospital pharmacies segment generated the largest market revenue of USD 3.3 billion in 2024 and is projected to reach USD 6.4 billion by 2034, witnessing its prominence throughout the forecast period at a CAGR of 6.9%.
 

• Veterinary hospitals provide on-site pharmacies ensure direct vaccine administration and reduces missed vaccination windows.
   
• Emerging economies are investing heavily in expanding their veterinary hospital and pharmacies network to strengthen livestock heath. For instance, India’s Animal Husbandry Infrastructure Development Fund (AHIDF) allocated over INR 15.000 crores to upgrade veterinary hospitals and equip their pharmacies with essential vaccines.
   
• Veterinary hospitals are a preferred choice for large scale farmers and commercial animal operations as they offer end-to-end care including diagnostics, consultation and vaccination.

In 2024, the U.S. hold a prominent position in the North American livestock vaccines market, reaching a valuation of USD 2.4 billion, up from USD 2.3 billion in 2023.
 

• U.S. prominence was asserted to the well-established animal healthcare infrastructure, high spending on animal healthcare and veterinary medicines including animal vaccines.
   
• Increasing prevalence of livestock diseases such as IBD, New Castle disease, and others have driven the need for prevent measures including the vaccination programs has boosted the market growth.
   
• For instance, as per the U.S. Centre of Disease Control and Prevention (CDC), a multistate outbreak of HPAI A(H5N1) bird flu in dairy cows was first reported on March 25, 2024. This is the first instance of these cow flu viruses being discovered within cows. While, since 2022, USDA APHIS has reported HPAI A (H5N1) virus detections in more than 200 mammals. This growing concern is expected to spur the need for effective preventive measures thereby stimulating market demand in the country.
   
• In addition, the growing awareness for minimizing the usage of antibiotics in livestock has further accelerated the vaccine uptake. The FDA’s guidance for industry #263 which was effective from June 2023, mandates the veterinary oversight for all medically important antibiotics used in animals. This has led to shift towards vaccines as a preventive tool strengthening the U.S. position in the industry.
   

Germany is poised to achieve significant growth in the Europe livestock vaccines market.
 

• The Germany’s growth was driven its large livestock base and strong veterinary infrastructure.
   
• Germany has over 21.2 million pigs, 10.5 million cattle and 13.1 billion eggs according to the Federal Statistical Office (Destatis). This huge number drives demand for preventive healthcare measures propelling the vaccination volume.
   
• Moreover, strong regulatory approval for animal welfare also stimulates market growth.
   
• As Germany has one of the most stringent animal welfare laws in Europe such as mandatory proactive health management in farms including vaccination as part of preventive care protocols. It has demonstrated strong position in the European industry.
   

The China livestock vaccines market is anticipated to witness rapid growth in Asia Pacific market in coming years.
 

• The growing emphasis on food safety and biosecurity, government-led disease control programs and country’s massive livestock population are fueling livestock vaccine market in China. As per Statista, in 2023, Chinas cattle and buffaloes livestock inventory amounted to around 103 million.
   
• Additionally, devastating outbreaks in the country like African Swine Fever (ASF) have had major economic consequences, culling of over 50% of China’s pig herd in 208-2019. This has led to accelerate the research activities in veterinary medicines and to develop effective preventive solutions catering to concerns towards animal health
   
• In response Chinese government has invested in developing a vaccine for the same. According to Chinese Academy of Agricultural Sciences (CAAS) in June 2020, the vaccine for the ASF which is being developed by Harbin Veterinary Research Institute under the CAAS is also showing positive results in the trial.
   
• Furthermore, the presence of leading players such as Boehringer Ingelheim, Jinyu, Shenlian Biotech, Merck has further strengthened the animal health industry in the country.
   

Brazil held a prominence position in the Latin America livestock vaccines market.
 

• Brazil maintains a strong position in the Latin American market due to its immense livestock population and sophisticated agricultural activities in the country.
   
• The country is the one of the world's largest exporters of beef and a major exporter of poultry and pork, creating vast and diverse business opportunities.
   
• Brazil has been highly spending on animal health programs catering to the animal health disease. For example, controlling FMD and maintaining disease free status for exports. Meanwhile, domestic policies such as ‘National Program for Control and Eradication of Foot and Mouth Diseases’ support further Brazil's leadership.
   
• However, the growing regulatory support coupled with the enhanced technology in vaccine production, Brazil will continue to be at the forefront in the production and utilization of veterinary vaccines.
   

Saudi Arabia’s livestock vaccines market is poised to grow at a considerable growth rate in Middle East and Africa market.
 

• Saudi Arabia’s growth is asserted to the growing focus on food security, increasing livestock production and rising public investment in veterinary health infrastructure under the broader Vision 2030 reforms.
   
• Despite the arid climate in the country, Saudi Arabia maintains a sizable livestock sector. According to the General Authority of Statistics, the country has 2.3 million cows, 7.4 million goats and 22 million sheep. This scale necessitates robust vaccination programs to prevent losses and safeguard food supply chains.
   
• Further, the country faces recurring disease outbreaks particularly in poultry and small ruminants which has significant economic implications and accelerate demand for the vaccines.
   

Livestock Vaccines Market Share

The top 5 players in the market generated ~45% of the market share. The leading key players such as Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco and Ceva dominated the industry through their extensive product portfolio, continuous investment in research and development and strong international presence.
 

The market is moderately consolidated with the key players focusing on developing next-gen vaccines using advanced technologies and strengthening their position in the market. In addition, the growing government support, increasing research and development and a shift toward preventive, sustainable, and cost-effective immunization strategies are shaping the markets growth.
 

Livestock Vaccines Market Companies

Few of the prominent players operating in the livestock vaccines industry include:

• Biogenesis Bago
• Bioveta
• Boehringer Ingelheim 
• Ceva
• Elanco
• HIPRA
• Indian Immunologicals
• Merck Animal Health
• Neogen
• Phibro Animal Health
• SAN VET
• Vaxxinova
• Venkys
• Virbac
• Zoetis

• Zoetis is a global leader in animal health space, with a robust vaccines portfolio. Its competitive edge lies in its early adoption of mRNA and DNA vaccines research and development and its broad-spectrum recombinant vaccines.
   
• Merck Animal Health’s robust portfolio of livestock vaccines has led its strong position in the industry. The company is known for its innovative research and development pipeline products and exclusive vaccine brands such as Nobivac and Bovilis, that offer cover across various viral and bacterial infections in multiple species.
   
• Elanco combines its legacy in livestock vaccines with its strong strategic mergers and acquisitions, giving it a strong footprint in livestock vaccine production.
   

Livestock Vaccines Industry News

• In January 2025, Vaxxinova received USDA approval for its of VAXXON SHS, a live avian metapneumovirus vaccine import in the U.S. This vaccine was used to protect against Swollen Head Syndrome in poultry. The first ever approval for import of live vaccines in the U.S. marked a significant milestone in the fight against Avian metapneumovirus (aMPV).
   
• In February 2025, Elanco partnered with Medgene enabling it to utilize Medgene’s innovative platform technology. Through this agreement, Medgene will commercialize the vaccine intended to be used for highly pathogenic avian influenza (HPAI) in dairy cattle. The expansion was focused on improving the range of preventive measures undertaken to combat disease.
   
• In November 2024, Ceva announced a new investment in the European vaccine manufacturing sector by building a new facility in Hungary, an expansion of Ceva Phylaxia. Ceva Phylaxia is focused on combating devastating diseases affecting livestock through innovative research and vaccine development. With this investment, the company aimed to enhance the vaccine manufacturing capabilities for vaccine development.
   

The livestock vaccines market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Animal Type

• Poultry
• Cattle 
• Swine 
• Aquaculture   
• Sheep and goats

Market, By Vaccine Type

• Attenuated live vaccine
• Conjugate vaccine
• Inactivated vaccine
• Recombinant vaccine
• Other vaccine types

Market, By Route of Administration

• Oral
• Parenteral
• Other routes of administration

Market, By Application

• Bacterial infections
• Viral infections
• Parasitic infections
• Other applications

Market, By Distribution Channel

• Veterinary hospital pharmacies
• Retail pharmacies
• E-commerce

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE